40
Participants
Start Date
September 30, 2005
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Bevacizumab
IV 15mg/kg 21 days
Cyclophosphamide
500mg per meter squared, IV every 21 days
Docetaxel
60 mg per meter squared, IV every 21 days
University of Arkansas for Medical Sciences, Little Rock
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of Arkansas
OTHER